2019
DOI: 10.1055/s-0039-1679958
|View full text |Cite
|
Sign up to set email alerts
|

Intraoperative Perfusion Assessment in Mastectomy Skin Flaps: How Close are We to Preventing Complications?

Abstract: Background Mastectomy flap necrosis is the source of considerable morbidity and cost following breast reconstruction. A great deal of effort has been put forth to predicting and even preventing its incidence intraoperatively. Methods A review of the literature was performed evaluating the evidence of mastectomy skin flap perfusion technologies. Results Multiple technologies have leveraged spectroscopy and/or angiography to provide real-time assessment of flap perfusion, including indocyanin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
40
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 30 publications
(40 citation statements)
references
References 64 publications
(91 reference statements)
0
40
0
Order By: Relevance
“…20 Commercially available systems, including the SPY, combine an infrared sensor, light source, and monitor that allow for the visualization of ICG throughout the tissue of interest. Preliminary studies have evaluated this technology in a variety of settings 3,8,10,11,[21][22][23] ; however, widespread adoption is limited by concerns regarding its specificity and cost efficacy, with an upfront device cost of roughly $250,000 and per-use cost of $650. 10,24 Our study serves as an important proof of concept for the use of NIRS, and specifically the ViOptix Intra.Ox, in bowel.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…20 Commercially available systems, including the SPY, combine an infrared sensor, light source, and monitor that allow for the visualization of ICG throughout the tissue of interest. Preliminary studies have evaluated this technology in a variety of settings 3,8,10,11,[21][22][23] ; however, widespread adoption is limited by concerns regarding its specificity and cost efficacy, with an upfront device cost of roughly $250,000 and per-use cost of $650. 10,24 Our study serves as an important proof of concept for the use of NIRS, and specifically the ViOptix Intra.Ox, in bowel.…”
Section: Discussionmentioning
confidence: 99%
“…Preliminary studies have evaluated this technology in a variety of settings 3,8,10,11,[21][22][23] ; however, widespread adoption is limited by concerns regarding its specificity and cost efficacy, with an upfront device cost of roughly $250,000 and per-use cost of $650. 10,24 Our study serves as an important proof of concept for the use of NIRS, and specifically the ViOptix Intra.Ox, in bowel. The output of the Intra.Ox is reported as composite tissue oxygenation, derived from blood, both arterial and venous, encompassed within the photon visitation depth of the device (approximately 1 mm for the Intra.Ox).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations